The association between CD2+ peripheral blood lymphocyte subsets and the relapse of bladder cancer in prophylactically BCG-treated patients

por Reyes, E, Carballido, J, Manzano, L, Moltó, L, Olivier, C, Alvarez-Mon, M
Publicado 1999

Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activation.

por Molto, L., Alvarez-Mon, M., Carballido, J., Manzano, L., Guillen, C., Prieto, A., Olivier, C., Rodriguez-Zapata, M.
Publicado 1994